Senior Product Manager - Inference
BenchSci
Product
Toronto, ON, Canada
CAD 150k-180k / year + Equity
You Will:
● Manage a Hybrid Inference Roadmap: Develop and execute a strategy for core prediction models that serves two distinct goals:
○ Productization into our core platform for the most high-usage use cases, and
○ Tech-enabled-Service for internal teams to deliver bespoke predictions to customers. You will ruthlessly prioritize to ensure the core inference engine evolves to support both, while minimizing forking.
● Navigate Internal Complexity: Act as a diplomat and strategist within the organization. You will bring clarity to complex, sometimes conflicting internal priorities, driving alignment between Engineering, Science, Go-to-Market, and Product leadership.
● Drive External Partnerships: Serve as the primary product interface for key partners helping to build and consume our predictions. You will translate partner scientific requirements into model capabilities, manage expectations around prediction accuracy/confidence, and ensure our technology creates value for them while remaining scalable for us.
● Bridge the Gap (Science <> ML): Translate preclinical business objectives into technical and data requirements. You will ensure that a single inference engine can effectively serve diverse use cases across the drug discovery pipeline (e.g., Target Identification vs. Safety Assessment vs. Study Design).
● Measure Impact: Define and report on metrics that capture the value of the platform, moving beyond just model performance (F1, Precision/Recall) to demonstrate business ROI and scientific utility to diverse internal stakeholders.
You Have:
● 5+ years, preferably 7+ years, as a Product Manager, with increasing responsibility on AI/ML or Data Science product
● Biopharma/Preclinical Fluency: You understand the drug discovery lifecycle (from Target ID to Lead Optimization). You can speak the language of scientists to understand the nuance of how a "prediction" helps or hinders their specific workflow. 2+ years experience working in the Biotech or Pharma industry is a strong plus, where you can bring a deep understanding of pre-clinical R&D to this role.
● Experience with Probabilistic Products: You have successfully managed products where the core value is a prediction or inference. You know how to handle user expectations around uncertainty, confidence scores, and false positives/negatives in high-stakes environments.
● Experience in Technology-as-a-Service: A proven track record managing inference technology that is consumed via API or service layer, where that same technology powers internal user-facing products.
● Exceptional Stakeholder Management: You excel at navigating internal politics and organizational dynamics. You have a history of driving consensus among strong-minded research scientists and engineers without having direct authority.
● Technical Fluency: Familiarity with LLMs, Knowledge Graphs, or predictive modeling. You don't need to write code, but you must be able to debate trade-offs (e.g., latency vs. accuracy, generalization vs. specificity) with engineering leads.
● Strategic Resilience: You are comfortable with ambiguity and can make data-informed decisions even when the path forward isn't obvious.
Compensation:
$150,000- $180,000 CAD • includes equity options
We know compensation is an important part of choosing your next role. The range shown reflects our target hiring range, informed by market data, internal equity, and the role's current scope. Often the mid-range is where we tend to fall, but individual offers may vary based on experience, skills, and the role scope.
BenchSci's mission is to unravel the complexity of disease biology for the betterment of patients. We do this by applying neuro-symbolic AI to unravel the black box of disease biology — the number one reason drug discovery projects fail.
Despite significant advancements, drug discovery still takes over a decade and billions of dollars — and 90% of clinical trials still fail. The core problem is getting the biology wrong before programs go to scale. BenchSci exists to fix that.
Our platform, ASCEND, is the world's first neuro-symbolic AI built for biopharma disease biology. It gives scientists clarity in hours or weeks that previously took months. Our platform is used by 9 of the top 10 pharmaceutical companies across 4,500+ research centers, and grew 247% over three years (Deloitte Fast 500, 2025). We've raised $200M+ from Generation Investment Management, Google's Gradient Ventures, TCV, and F-Prime.